We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Victory Capital (VCTR) February AUM Up on Higher Equity Assets
Read MoreHide Full Article
Victory Capital Holdings (VCTR - Free Report) announced assets under management (AUM) by its subsidiaries of $150.6 billion for February 2021. The results reflect a 3% rise from $146.2 billion reported on Jan 31, 2021.
At the end of February, the company’s U.S. Mid Cap Equity AUM increased nearly 7.7% from January to $27.9 billion. U.S. Small Cap Equity of $19.6 billion rose 8%. Further, U.S. Large Cap Equity AUM and Global/Non-U.S. Equity AUM climbed 2.6% and 2.5%, respectively, from the previous month to $14.2 billion and $14.3 billion.
Victory Capital recorded $34.2 billion in Solutions, up 1.1% from $33.8 billion reported in January. Other assets increased 22.1% to $326 million on a sequential basis. Also, Fixed Income assets were $36.7 billion, which declined marginally.
Sound positioning of Victory Capital’s integrated multi-boutique business model in a rapidly evolving industry and effectiveness of the distribution platform might keep supporting its performance.
Shares of the company have gained 49.6% over the past six months, outperforming the industry’s 33% rally.
Cohen & Steers (CNS - Free Report) reported preliminary AUM balance of $83.1 billion as of Feb 28, 2021, which reflects an increase of 2.4% from the prior-month level. Net inflows of $229 million and market appreciation of $1.9 billion were partially offset by distributions of $202 million.
Invesco Ltd. (IVZ - Free Report) announced preliminary month-end AUM of $1391.5 billion, up 1.8% from previous month. Positive market returns aided this growth, boosting the AUM by $13 billion.
Franklin Resources (BEN - Free Report) recorded preliminary AUM balance of $1500.5 billion for February 2021. This reflects marginal growth from $1494.4 billion recorded as of Jan 31, 2021. The improvement in AUM balance mainly reflects benefits from market appreciation and long-term net inflows.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Victory Capital (VCTR) February AUM Up on Higher Equity Assets
Victory Capital Holdings (VCTR - Free Report) announced assets under management (AUM) by its subsidiaries of $150.6 billion for February 2021. The results reflect a 3% rise from $146.2 billion reported on Jan 31, 2021.
At the end of February, the company’s U.S. Mid Cap Equity AUM increased nearly 7.7% from January to $27.9 billion. U.S. Small Cap Equity of $19.6 billion rose 8%. Further, U.S. Large Cap Equity AUM and Global/Non-U.S. Equity AUM climbed 2.6% and 2.5%, respectively, from the previous month to $14.2 billion and $14.3 billion.
Victory Capital recorded $34.2 billion in Solutions, up 1.1% from $33.8 billion reported in January. Other assets increased 22.1% to $326 million on a sequential basis. Also, Fixed Income assets were $36.7 billion, which declined marginally.
Sound positioning of Victory Capital’s integrated multi-boutique business model in a rapidly evolving industry and effectiveness of the distribution platform might keep supporting its performance.
Shares of the company have gained 49.6% over the past six months, outperforming the industry’s 33% rally.
Currently, Victory Capital carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performance of Other Asset Managers
Cohen & Steers (CNS - Free Report) reported preliminary AUM balance of $83.1 billion as of Feb 28, 2021, which reflects an increase of 2.4% from the prior-month level. Net inflows of $229 million and market appreciation of $1.9 billion were partially offset by distributions of $202 million.
Invesco Ltd. (IVZ - Free Report) announced preliminary month-end AUM of $1391.5 billion, up 1.8% from previous month. Positive market returns aided this growth, boosting the AUM by $13 billion.
Franklin Resources (BEN - Free Report) recorded preliminary AUM balance of $1500.5 billion for February 2021. This reflects marginal growth from $1494.4 billion recorded as of Jan 31, 2021. The improvement in AUM balance mainly reflects benefits from market appreciation and long-term net inflows.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>